News Chimeric Therapeutics Limited

Equities

CHM

AU0000121576

Market Closed - Australian S.E. Other stock markets 02:10:53 2024-05-31 am EDT			5-day change	1st Jan Change
0.018 ^AUD	-.--%		-21.74%	-48.57%

May. 22	Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4%	MT
May. 20	Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4%	May. 21	MT
Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial	May. 19	MT
Chimeric Therapeutics Reopens Enrollment in Phase 1B Cell Therapy Study	May. 15	MT
Chimeric Therapeutics Appoints COO; Shares Rise 4%	May. 01	MT
Chimeric Therapeutics' CEO/Managing Director Steps Down; Shares Plunge 20%	Apr. 30	MT
Chimeric Therapeutics Obtains Patent Application Covering CORE-NK Technology; Shares Up 3%	Apr. 04	MT
Chimeric Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
Chimeric Therapeutics Treats First Patient in Phase 1B Leukemia Trial	Feb. 08	MT
Chimeric Therapeutics to Raise AU$3.2 Milion Via Shortfall Placement	Jan. 18	MT
Chimeric Therapeutics Opens Phase 1B Leukemia Trial	Jan. 14	MT
Chimeric Therapeutics Receives AU$7 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%	Jan. 09	MT
Chimeric Therapeutics Secures AU$1 Million via Share Placement Deal	Jan. 04	MT
Chimeric Therapeutics Extends Closing Date of AU$10 Million Entitlement Offer	Nov. 15	MT
Chimeric Therapeutics Doses First Patient in Phase 1B Clinical Trial for Brain Cancer	Nov. 01	MT
Chimeric Therapeutics Announces FDA Clearance of IND Application for CHM 2101	23-10-31	CI
Australian Shares Rebound Ahead of US Fed Policy Meeting	23-10-31	MT
US FDA Gives Green Signal to Chimeric Therapeutics' IND Application for Gastrointestinal Cancer Drug; Shares Jump 65%	23-10-30	MT
Chimeric Therapeutics to Raise AU$10 Million from Entitlement Offer	23-10-25	MT
Chimeric Therapeutics Signs Deal to Support Leukemia Trial	23-09-13	MT
Chimeric Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Chimeric Therapeutics Limited

Equities

CHM

AU0000121576

Summary

Filters